RecruitingNot ApplicableNCT05292989

A Personalised Approach Utilising the Frailty Index to Empower Consumers

A Personalised Approach Utilising the Frailty Index to Empower Consumers to Make Informed Decisions About Having a Colonoscopy to Avoid Low Value Care. A Prospective Randomized Controlled Trial.


Sponsor

Princess Alexandra Hospital, Brisbane, Australia

Enrollment

200 participants

Start Date

Aug 14, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Frailty is a common clinical syndrome in older adults that may carry an increased risk for poor health outcomes including falls, hospitalisation, and mortality. Having a colonoscopy can be associated with potential adverse outcomes in frail patients. At present, however, frailty is not routinely assessed in gastroenterological clinical practice. In a prospective randomised controlled study consenting patients over 65 years at the Princess Alexandra Hospital will receive either a) personalised (tailored) approach that includes assessment of frailty and structured information provided to the consumer or b) current standard practice in regards to having a surveillance colonoscopy to determine the effects on patient satisfaction and percentage of colonoscopies avoided.


Eligibility

Min Age: 65 YearsMax Age: 100 Years

Inclusion Criteria2

  • Patients aged over 65 years of age
  • Ability to understand the study instructions and answering questionnaires

Exclusion Criteria2

  • Inability to consent or participate in the assessments (e.g. frailty assessment) that are required as part of this project.
  • Lack of informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERFrailty Assessment

Personalised (tailored) approach that includes assessment of frailty and structured information provided to the consumer

OTHERStandard Care

Standard care practice


Locations(1)

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05292989


Related Trials